Mara Di Martino She has a degree in Biotechnology and Molecular Biology from the University of La Plata, a true Argentinean pride. The young scientist presented a project related to brain tumors with major contributions to this topic. right, She received a grant from a British institution so that she could continue her research at New York University..
“In the lab, we deal with brain tumors, particularly a type of one called glioblastoma, which is… brain tumor It is more common in adults and is one of the most aggressive cancers out there because the survival time for patients is less than 15 months. The Argentine scientist told TN that the problem with this type of tumor is that once diagnosed, it is generally treated with surgery, chemotherapy and radiotherapy, but after a while the tumors appear again.
This happens because tumors develop different mechanisms or strategies to become resistant to treatment or to avoid evading the attack of our immune system. Within this project we are studying in the laboratory which are different mechanisms or strategies for resistance to these tumors, I made a project for this funding scheme or a grant from a foundation called ‘Brain Tumor Charity’, it’s from the UK and what it does is funding, initially for 3 years, but can be extended up to 12, research projects involving brain tumorsshe narrowed.
What is the aim of the young scholarship project?
“In this scholarship, they have provided 6 opportunities for 6 people around the world to investigate this topic, especially in this project, where it is concerned with characterizing or studying one of these mechanisms or strategies that develop tumors in order to Avoid immune system attack It becomes resistant to treatments. In my case, I’m studying radiotherapy resistance,” DiMartino said.
TargetThe young woman says, “The search for new therapeutic strategies or new therapies for these brain tumors. In my case, what I have seen is that tumor metabolism and the immune system can be a therapeutic target for sensitization, for example, and oncology for radiotherapy.”
“he Basic research project This will be done in cells and animals, and ultimately, with these results, it’s possible, after those three years, to consider validation, human samples from patients, and eventually, design a clinical trial where what we’re going for will be tumor metabolite inhibition in combination with therapeutics. conventional radiotherapy.
You may also be interested> They discover a bird that lived with the dinosaurs in Santa Cruz
“Subtly charming bacon junkie. Infuriatingly humble beer trailblazer. Introvert. Evil reader. Hipster-friendly creator.”